Home › Funding Recipients

We will upload information about the latest recipients to have been awarded HRC funding for all of our funding opportunities as this information becomes officially available.

The information provided is for ‘year to date’ funding.

Previous Recipient List

  • 2008 Funding Round
    Professor Edward Baker
    The University of Auckland
    Structural and molecular basis of host-pathogen interactions
    $1,496,780
    36 months
  • 2006 Funding Round
    Professor Edward Baker
    The University of Auckland
    A targeted application of structural genomics to TB biology and drug development
    $1,375,181
    36 months
  • 2016 Funding Round - Project
    Professor Michael Baker
    University of Otago, Wellington
    Understanding GAS pharyngitis and skin infections as causes of rheumatic fever
    $1,197,693
    36 months
    Lay summary
  • 2009 Funding Round
    Ms Mere Balzer
    Te Runanga o Kirikiriroa Charitable Trust
    Whanau Māori & mental health: Snapshots of strengths, resilience & recovery
    $132,483
    18 months
  • 2007 Funding Round
    Dr Suzanne Barker-Collo
    Auckland UniServices Ltd
    Reducing post-stroke attention deficits: Extending a randomised controlled trial
    $60,000
    36 months
  • 2006 Funding Round
    Dr Suzanne Barker-Collo
    Auckland UniServices Ltd
    Reducing post-stroke attention deficits: a randomised controlled trial
    $479,032
    36 months
  • 2011 Funding Round
    Professor Richard Beasley
    Medical Research Institute of New Zealand, Wellington
    Randomised Placebo-controlled Trial of Paracetamol in Febrile Septic Patients
    $1,197,966
    36 months
  • 2010 Funding Round
    Professor Richard Beasley
    Medical Research Institute of New Zealand
    A randomised placebo-controlled trial of paracetamol use in influenza
    $747,053
    18 months
  • 2010 Funding Round
    Professor Richard Beasley
    Medical Research Institute of New Zealand
    RCT of regular paracetamol in mild to moderate asthma
    $342,220
    24 months
  • 2010 Funding Round
    Professor Richard Beasley
    Medical Research Institute of New Zealand
    Pharmacotherapy for the different phenotypes of airways disease
    $1,200,000
    36 months
  • 2009 Funding Round
    Professor Richard Beasley
    Medical Research Institute of New Zealand
    The Real Life Use of Symbicort "Smart" Regime in Adult Asthma
    $1,302,654
    36 months
  • 2007 Funding Round
    Professor Richard Beasley
    Medical Research Institute of New Zealand
    Bronchodilator efficacy of inhaled magnesium in acute severe asthma and COPD
    $1,120,318
    24 months
  • 2008 Funding Round
    Professor Evan Begg
    University of Otago, Christchurch
    Free drug metabolic clearance in older adults
    $326,366
    24 months
  • 2011 Funding Round
    Professor Laura Bennet
    The University of Auckland
    Can Pluripotent Amnion Epithelial Cells help the Injured Preterm Brain?
    $1,154,402
    36 months
  • 2014 Funding Round – Project
    Dr Peter Bergin
    Auckland District Health Board
    Incidence study of Status Epilepticus in the greater Auckland region
    $671,783
    60 months
    Lay summary
  • 2016 Funding Round - Programme
    Professor Michael Berridge
    Malaghan Institute of Medical Research
    Intercellular mitochondrial transfer in glioblastoma
    $1,095,885
    36 months
    Lay summary
  • 2008 Funding Round
    Associate Professor David Bilkey
    University of Otago, Dunedin
    Hippocampal processing of context in schizophrenia
    $796,117
    36 months
  • 2006 Funding Round
    Dr David Bilkey
    University of Otago
    Hippocampal processing of context in schizophrenia
    $415,008
    24 months
  • 2009 Funding Round
    Associate Professor Peter Black
    The University of Auckland
    The effect of an inhaler with ringtones on asthma control and school attendance
    $428,355
    24 months
  • 2006 Funding Round
    Associate Professor Tony Blakely
    University of Otago
    Cancer trends: Ethnic and socio-economic trends in cancer incidence and survival
    $924,356
    36 months